glp-1 inhibitor drugs List of approved and pending medications GLP-1 Drugs: Where We Are
Description
Clinical Significance: The 2025 updates reaffirm that while HbA1c remains central, a one-number-fits-all strategy is outdated
People rush to the gym as soon as the new year starts to start prepping for the perfect body for summer
Average cost-sharing for a one-month supply of GLP-1 medications ranged from $61 to $93 in 2023
Learn the benefits, risks, and if this modern approach is right for you.
Retatrutide vs Semaglutide: Evidence-based comparison of the investigational triple GIP/GLP-1/glucagon agonist versus the FDA-approved GLP-1 agonist
Pfizer is developing a long-acting GLP-1 drug that could compete directly with Eli Lilly's Mounjaro and Zepbound when it reaches the Canadian market.
